IDEAYA Biosciences

IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Our approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from our targeted therapies. IDEAYA is headquartered in South San Francisco, California.

Nasdaq: IDYA
IR Website:
Headquarters: South San Francisco, CA

Content provided by IDEAYA Biosciences on 2-7-22.


The IDEAYA Biosciences management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.


Investor Presentation

Management Overview

Risks & Disclosures